Researchers develop a new class of covalent inhibitor for a protein involved in brain diseases Blog Post

An article published in Cell Chemical Biology by scientists at the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona Science Park (PCB) describes a new class of prolyl oligopeptidase (POP) inhibitors. Found mostly in the brain, POP protein has emerged as an “attractive·” therapeutic target for the treatment of several cognitive and neurodegenerative disorders, such as Parkinson’s disease and schizophrenia.The work was done in collaboration with the biotech Iproteos, based in PCB and scientists at the University of Glasgow (Scotland, UK) and the Utrecht Institute for Pharmaceutical Sciences (the Netherlands). The study has also involved the Nuclear Magnetic Resonance Laboratory (LRB) –wich is part of CCiTUB and it’s located in the Cluster building of the Park– and the Barcelona Supercomputing Center (BSC).

 

Scientific and Technological Centers UB: 30 years of technology serving research and innovation Blog Post

The Scientific and Technological Centers of the University of Barcelona (CCiTUB) reached their first thirty years of activity over which they have become widely known in both the national and international fields of research, innovation, and transfer. At the moment, the team in CCiTUB is formed by a hundred and sixty experts and administration staff, and eighty of tem are doctors, distributed in thirty-eight units, six of which are located in the Barcelona Science Park (PCB), among which there is the Nuclear Magnetic Resonance Laboratory (LRB), listed in the Map of Unique Scientific and Technical Infraestructures (ICTS). 

 

EIT Health Wild Card: €4 million in search of innovative health ideas Blog Post

Under the new Wild Card programme, EIT Health consortium –the largest European body for innovation in healthy living and active ageing– has announced €4 million in funding for disruptive initiatives that help transform European healthcare and mitigate the social and economic impact of the progressive ageing of the population. The Universitat de Barcelona (UB), a core partner and promoter of EIT Health Spain, is one of the 14 European institutions that will offer advisory and incubation services to the two winning teams to turn their ideas into a business plan through of the Barcelona Entrepreneurship Institute (BIE), the Bosch i Gimpera Foundation (FBG) and the Barcelona Science Park (PCB). On Monday, January 29, an informative session will take place at the PCB.

 

IBEC celebrates 10 years of excellent interdisciplinary research Blog Post

2017 sees the Institute for Bioengineering of Catalonia (IBEC) celebrate its first ten years of research activity. lt’s been a hair-raisingly fast climb up to the near top of the tree of centres in the Catalan research arena, with IBEC already holding its own alongside bigger and more established organizations for scientific output, number of ERC grants, patents, spin-offs, training programmes, national or EU-level stamps and endorsements, and other important indicators. Yesterday, the 10th Anniversary Commemorative Ceremony and this week’s Symposium on Bioengineering for Future Medicine at the AXA Auditorium kicked off the celebrations.

 

Drug repurposing, a new hope for rare diseases Blog Post

Under the theme Drug repurposing for rare diseases. The cure of the 21st centuryB·Debate – an initiative by Biocat and  “la Caixa” Foundation– will be holding, in association with the Barcelona Science Park (PCB) and Hospital Sant Joan de Déu (HSJD), an international expert gathering at CosmoCaixa on 17 and 18 November to help identify new therapeutic strategies for rare diseases, with a special emphasis on drug repurposing already approved for other diseases. 

 

Researchers froms IBEC and UB have collaborated in the definition of a new kind of indicators for bacterial virulence Blog Post

Researchers and the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona (UB) together with their collaborators from the University of Santiago de Compostela (USC), the Institute of Medical Microbiology and Hygiene (University of Lübeck) and German Center for Infection Research (DZIF) have determined a new kind of indicators for bacterial virulence which can help detect and preventing infection outbreaks caused by Escherichia coli.